Global Patent Index - EP 4310503 A3

EP 4310503 A3 20240320 - METHODS RELATED TO BIOLOGICS

Title (en)

METHODS RELATED TO BIOLOGICS

Title (de)

VERFAHREN IM ZUSAMMENHANG MIT BIOLOGIKA

Title (fr)

MÉTHODES ASSOCIÉES À DES PRODUITS BIOLOGIQUES

Publication

EP 4310503 A3 20240320 (EN)

Application

EP 23201801 A 20161228

Priority

  • US 201562273337 P 20151230
  • EP 16882558 A 20161228
  • US 2016068871 W 20161228

Abstract (en)

The present disclosure relates to the characterization and production of biologics.

IPC 8 full level

A61K 39/395 (2006.01); C12P 21/00 (2006.01); G01N 33/68 (2006.01)

CPC (source: EP US)

C07K 14/54 (2013.01 - US); C07K 14/5434 (2013.01 - US); C07K 16/244 (2013.01 - EP US); C12P 21/005 (2013.01 - EP US); G01N 33/6854 (2013.01 - EP US); C07K 2317/14 (2013.01 - EP US); C07K 2317/21 (2013.01 - EP US); C07K 2317/30 (2013.01 - EP US); C07K 2317/41 (2013.01 - EP US); G01N 2440/38 (2013.01 - EP US)

Citation (search report)

  • [Y] US 2014359902 A1 20141204 - ARIAANS GERARDUS JOSEPH ANDREAS [NL], et al
  • [A] WO 2013181575 A2 20131205 - MOMENTA PHARMACEUTICALS INC [US]
  • [A] WO 2013181586 A2 20131205 - MOMENTA PHARMACEUTICALS INC [US]
  • [Y] SMITH: "European Medicines Agency Evaluation of Medicines for Human Use", 1 January 2009 (2009-01-01), XP055598866, Retrieved from the Internet <URL:https://www.ema.europa.eu/documents/assessment-report/stelara-epar-public-assessment-report_en.pdf> [retrieved on 20190624]
  • [Y] FOURNIER JENNIFER: "A Review of Glycan Analysis Requirements", BIOPHARM INTERNATIONAL, BIOPHARM INTERNATIONAL-10-01-2015, VOLUME 28, ISSUE 10, 1 October 2015 (2015-10-01), pages 32 - 37, XP055805741, Retrieved from the Internet <URL:https://www.biopharminternational.com/view/review-glycan-analysis-requirements> [retrieved on 20210519]
  • [A] GILAR MARTIN ET AL: "Rapid Assessment of Molecular Similarity between a Candidate Biosimilar and an Innovator Monoclonal Antibody Using Complementary LC-MS Methods", BIOPHARM INTERNATIONAL, vol. 23, no. 8 SUPPL, 1 August 2010 (2010-08-01), pages 16 - 21, XP055805745
  • [A] LEI ZHANG ET AL: "Glycan analysis of therapeutic glycoproteins", MABS, vol. 8, no. 2, 24 November 2015 (2015-11-24), US, pages 205 - 215, XP055568801, ISSN: 1942-0862, DOI: 10.1080/19420862.2015.1117719
  • [A] IVAN SANCHEZ-DE MELO ET AL: "N-glycosylation profile analysis of Trastuzumab biosimilar candidates by Normal Phase Liquid Chromatography and MALDI-TOF MS approaches", JOURNAL OF PROTEOMICS, vol. 127, 1 September 2015 (2015-09-01), AMSTERDAM, NL, pages 225 - 233, XP055233199, ISSN: 1874-3919, DOI: 10.1016/j.jprot.2015.04.012

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

DOCDB simple family (publication)

WO 2017117218 A1 20170706; EP 3397282 A1 20181107; EP 3397282 A4 20190807; EP 4310503 A2 20240124; EP 4310503 A3 20240320; US 11719704 B2 20230808; US 2019025325 A1 20190124; US 2023324406 A1 20231012

DOCDB simple family (application)

US 2016068871 W 20161228; EP 16882558 A 20161228; EP 23201801 A 20161228; US 201616067411 A 20161228; US 202318331803 A 20230608